Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home
  • Log in
  • My Cart

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
Research Article

Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery

Shrirang Karve, Michael E. Werner, Rohit Sukumar, Natalie D. Cummings, Jonathan A. Copp, Edina C. Wang, Chenxi Li, Manish Sethi, Ronald C. Chen, Michael E. Pacold, and Andrew Z. Wang
  1. aLaboratory of Nano- and Translational Medicine, Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599;
  2. bCarolina Center for Cancer Nanotechnology Excellence, University of North Carolina, Chapel Hill, NC 27599;
  3. cDepartment of Biostatistics and NC TraCS Institute, University of North Carolina, Chapel Hill, NC 27599;
  4. dDepartment of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599; and
  5. eHarvard Radiation Oncology Program, Brigham and Women‘s Hospital, Boston, MA 02215

See allHide authors and affiliations

PNAS first published April 30, 2012; https://doi.org/10.1073/pnas.1120508109
Shrirang Karve
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael E. Werner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rohit Sukumar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie D. Cummings
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan A. Copp
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edina C. Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chenxi Li
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manish Sethi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald C. Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael E. Pacold
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Z. Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: zawang@med.unc.edu
  1. Edited by Robert Langer, Massachusetts Institute of Technology, Cambridge, MA, and approved April 12, 2012 (received for review December 13, 2011)

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Abstract

One of the promises of nanoparticle (NP) carriers is the reformulation of promising therapeutics that have failed clinical development due to pharmacologic challenges. However, current nanomedicine research has been focused on the delivery of established and novel therapeutics. Here we demonstrate proof of the principle of using NPs to revive the clinical potential of abandoned compounds using wortmannin (Wtmn) as a model drug. Wtmn is a potent inhibitor of phosphatidylinositol 3′ kinase-related kinases but failed clinical translation due to drug-delivery challenges. We engineered a NP formulation of Wtmn and demonstrated that NP Wtmn has higher solubility and lower toxicity compared with Wtmn. To establish the clinical translation potential of NP Wtmn, we evaluated the therapeutic as a radiosensitizer in vitro and in vivo. NP Wtmn was found to be a potent radiosensitizer and was significantly more effective than the commonly used radiosensitizer cisplatin in vitro in three cancer cell lines. The mechanism of action of NP Wtmn radiosensitization was found to be through the inhibition of DNA-dependent protein kinase phosphorylation. Finally, NP Wtmn was shown to be an effective radiosensitizer in vivo using two murine xenograft models of cancer. Our results demonstrate that NP drug-delivery systems can promote the readoption of abandoned drugs such as Wtmn by overcoming drug-delivery challenges.

  • nanotechnology
  • nanoparticle radiosensitizer

Footnotes

  • ↵1S.K. and M.E.W. contributed equally to this work.

  • ↵2To whom correspondence should be addressed. E-mail: zawang{at}med.unc.edu.
  • Author contributions: S.K., M.E.W., R.C.C., M.E.P., and A.Z.W. designed research; S.K., M.E.W., R.S., N.D.C., J.A.C., and E.C.W. performed research; C.L. contributed new reagents/analytic tools; S.K., M.E.W., R.S., N.D.C., J.A.C., C.L., R.C.C., and A.Z.W. analyzed data; and S.K., M.E.W., M.S., M.E.P., and A.Z.W. wrote the paper.

  • The authors declare no conflict of interest.

  • This article is a PNAS Direct Submission.

  • This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1120508109/-/DCSupplemental.

Next
Back to top
Article Alerts
Email Article

Thank you for your interest in spreading the word on PNAS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery
(Your Name) has sent you a message from PNAS
(Your Name) thought you would like to see the PNAS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Nanoparticle wortmannin as a radiosensitizer
Shrirang Karve, Michael E. Werner, Rohit Sukumar, Natalie D. Cummings, Jonathan A. Copp, Edina C. Wang, Chenxi Li, Manish Sethi, Ronald C. Chen, Michael E. Pacold, Andrew Z. Wang
Proceedings of the National Academy of Sciences Apr 2012, 201120508; DOI: 10.1073/pnas.1120508109

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Nanoparticle wortmannin as a radiosensitizer
Shrirang Karve, Michael E. Werner, Rohit Sukumar, Natalie D. Cummings, Jonathan A. Copp, Edina C. Wang, Chenxi Li, Manish Sethi, Ronald C. Chen, Michael E. Pacold, Andrew Z. Wang
Proceedings of the National Academy of Sciences Apr 2012, 201120508; DOI: 10.1073/pnas.1120508109
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Mendeley logo Mendeley
Proceedings of the National Academy of Sciences: 118 (16)
Current Issue

Submit

Sign up for Article Alerts

Jump to section

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF

You May Also be Interested in

Reflection of clouds in the still waters of Mono Lake in California.
Inner Workings: Making headway with the mysteries of life’s origins
Recent experiments and simulations are starting to answer some fundamental questions about how life came to be.
Image credit: Shutterstock/Radoslaw Lecyk.
Depiction of the sun's heliosphere with Voyager spacecraft at its edge.
News Feature: Voyager still breaking barriers decades after launch
Launched in 1977, Voyagers 1 and 2 are still helping to resolve past controversies even as they help spark a new one: the true shape of the heliosphere.
Image credit: NASA/JPL-Caltech.
Drop of water creates splash in a puddle.
Journal Club: Heavy water tastes sweeter
Heavy hydrogen makes heavy water more dense and raises its boiling point. It also appears to affect another characteristic long rumored: taste.
Image credit: Shutterstock/sl_photo.
Mouse fibroblast cells. Electron bifurcation reactions keep mammalian cells alive.
Exploring electron bifurcation
Jonathon Yuly, David Beratan, and Peng Zhang investigate how electron bifurcation reactions work.
Listen
Past PodcastsSubscribe
Panda bear hanging in a tree
How horse manure helps giant pandas tolerate cold
A study finds that giant pandas roll in horse manure to increase their cold tolerance.
Image credit: Fuwen Wei.

Similar Articles

Site Logo
Powered by HighWire
  • Submit Manuscript
  • Twitter
  • Facebook
  • RSS Feeds
  • Email Alerts

Articles

  • Current Issue
  • Special Feature Articles – Most Recent
  • List of Issues

PNAS Portals

  • Anthropology
  • Chemistry
  • Classics
  • Front Matter
  • Physics
  • Sustainability Science
  • Teaching Resources

Information

  • Authors
  • Editorial Board
  • Reviewers
  • Subscribers
  • Librarians
  • Press
  • Cozzarelli Prize
  • Site Map
  • PNAS Updates
  • FAQs
  • Accessibility Statement
  • Rights & Permissions
  • About
  • Contact

Feedback    Privacy/Legal

Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490